MultiPlan (MPLN) Stock Price, News & Analysis

Company Overview

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Key Stats

• Today's Range: $36.29 to $42.01
• 50-Day Range: $26.56 to $49.94
• 52-Week Range: $4.80 to $29.84
• Volume: 114,001 shs
• Average Volume: 123,649 shs
• Market Capitalization: $641.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $26.25
• Consensus Rating: Hold

MPLN Stock Analysis - Frequently Asked Questions

How have MPLN shares performed this year?

MultiPlan's stock was trading at $14.78 on January 1st, 2025. Since then, MPLN shares have increased by 168.5% and is now trading at $39.68.

How were MultiPlan's earnings last quarter?

MultiPlan Co. (NYSE:MPLN) issued its earnings results on Thursday, August, 1st. The company reported ($1.20) earnings per share for the quarter, topping the consensus estimate of ($1.60) by $0.40. The business had revenue of $233.48 million for the quarter, compared to the consensus estimate of $253.59 million. MultiPlan had a negative trailing twelve-month return on equity of 12.14% and a negative net margin of 163.30%.
Read the conference call transcript.

When did MultiPlan's stock split?

MultiPlan shares reverse split before market open on Monday, September 23rd 2024.The 1-40 reverse split was announced on Tuesday, September 10th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of MultiPlan?

Shares of MPLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MultiPlan own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MultiPlan investors own include Organigram Global (OGI), Ford Motor (F), NVIDIA (NVDA), Lucid Group (LCID), ChargePoint (CHPT) and i3 Verticals (IIIV).

Company Calendar

• Last Earnings: 8/01/2024
• Today: 7/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Business services, not elsewhere classified
• Sub-Industry: Business Services
• Current Symbol: NYSE:MPLN
• CIK: 1793229
• Web: www.multiplan.us
• Phone: 212-780-2000
• Fax: N/A
• Employees: 170
• Year Founded: N/A

Price Target and Rating

• Average Price Target for MultiPlan: $26.25
• High Price Target: $40.00
• Low Price Target: $12.50
• Potential Upside/Downside: -33.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($101.54)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$91.70 million
• Net Margins: -163.30%
• Pretax Margin: -171.48%
• Return on Equity: -12.14%
• Return on Assets: -1.84%

Debt

• Debt-to-Equity Ratio: 21.73
• Current Ratio: 1.05
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $930.62 million
• Price / Sales: 0.69
• Cash Flow: $24.20 per share
• Price / Cash Flow: 1.64
• Book Value: $105.45 per share
• Price / Book: 0.38

Miscellaneous

• Outstanding Shares: 16,171,000
• Free Float: 14,877,000
• Market Cap: $641.67 million
• Optionable: Optionable
• Beta: 0.13